EyePoint Pharmaceuticals
EYPT
#5166
Rank
โ‚น136.73 B
Marketcap
โ‚น1,652
Share price
3.38%
Change (1 day)
120.43%
Change (1 year)

Revenue for EyePoint Pharmaceuticals (EYPT)

Revenue in 2025 (TTM): โ‚น3.62 Billion

According to EyePoint Pharmaceuticals 's latest financial reports the company's current revenue (TTM ) is โ‚น3.81 Billion. In 2024 the company made a revenue of โ‚น3.71 Billion a decrease over the revenue in the year 2023 that were of โ‚น3.83 Billion. The revenue is the total amount of income that a company generates by the sale of goods or services. Unlike with the earnings no expenses are subtracted.

Revenue history for EyePoint Pharmaceuticals from 2003 to 2025

Annual revenue

Year Revenue Change
2025 (TTM) โ‚น3.62 B-2.3%
2024 โ‚น3.71 B-3.1%
2023 โ‚น3.83 B11.81%
2022 โ‚น3.42 B24.62%
2021 โ‚น2.74 B9.17%
2020 โ‚น2.51 B73.43%
2019 โ‚น1.45 B
2017 โ‚น0.16 B-64.35%
2016 โ‚น0.46 B306.66%
2015 โ‚น0.11 B-93.55%
2014 โ‚น1.78 B1214.46%
2013 โ‚น0.13 B4.23%
2012 โ‚น0.13 B-61.37%
2011 โ‚น0.33 B-56.13%
2010 โ‚น0.76 B25.28%
2009 โ‚น0.61 B41.28%
2008 โ‚น0.43 B1371.16%
2007 โ‚น29.47 M-67.7%
2006 โ‚น91.24 M49.68%
2005 โ‚น60.95 M225.77%
2004 โ‚น18.71 M131.43%
2003 โ‚น8.08 M

Revenue for similar companies or competitors

Company Revenue Revenue differencediff. Country
NRC Health
NRC
โ‚น12.52 B 228.54%๐Ÿ‡บ๐Ÿ‡ธ USA
Nymox Pharmaceutical
NYMX
N/AN/A Bahamas